Supreme Court has expressly acknowledged that off-label use by medical professionals is not merely legitimate, but important in the practice of medicine
In addition, Novo Nordisk conducted a pooled analysis of all randomized, placebo-controlled trials of liraglutide and semaglutide (involving more than 96,000 patients) and found no increased risk of NAION associated with either GLP-1 therapy." Wirth lost a lot when she lost her eyesight
Stick with established NAD protocols unless your practitioner explains a medical reason for customizations
Some protocols use both together for 4-6 weeks, then taper
Hypoglycemia less than 54mg/dL was reported in 6.7%, 5.5% and 6.5% of patients treated with tirzepatide 5mg, 10mg, and 15mg, respectively, and in 15% of those who received insulin glargine